Jadelind Wong has a diverse work experience spanning multiple industries. Jadelind started their career as a Research and Development Intern at AmCyte Diabetes Inc. in 2005. Jadelind then joined PrimeGen Biotech, LLC in 2006 as a Research Associate, where they played a key role in investigating DNA and protein delivery into cells using novel nano and small particle technology. Wong also secured budget for expanding a pilot study project to become one of the company's main research and development platforms.
In 2008, Wong moved to ReproCyte (formerly PrimeGen Biotech) as a Business Development and Marketing Manager, focusing on regenerative medicine therapies.
In 2011, Wong worked as an Investment Banking Summer Associate at Morgan Stanley, gaining exposure to IPOs, public equity issuances, M&A, and debt issuances in the healthcare sector. Jadelind later returned to Morgan Stanley in 2012 as an Investment Banking Associate, focusing on healthcare clients and performing various valuation analyses.
In 2015, Wong joined Strathspey Crown LLC as a Director, leading initiatives in identifying and evaluating companies in the healthcare technology and self-pay medical products sectors. Jadelind also worked closely with managing partners of a healthcare royalty/structured credit fund subsidiary.
Wong's most recent role, starting in 2016, was as an Interim CEO of a start-up in automated bargaining.
Jadelind Wong attended Monta Vista High School, although the specific years are not provided. Following high school, they enrolled in UCLA, where they pursued a Bachelor of Science degree in Microbiology, Immunology, and Molecular Genetics from 2002 to 2006. After completing their undergraduate studies, Jadelind then pursued a Master of Business Administration (MBA) degree at Harvard Business School from 2010 to 2012.
Sign up to view 4 direct reports
Get started
This person is not in any teams